Amneal Pharmaceuticals, Inc. AMRX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $197.66M+234% | $282.03M+155% | $201.25M+172% | $71.54M+63.5% | $59.19M+27.2% | ||
| -$44.01M-108% | $10.34M-63.9% | $77.61M— | $53.76M-46.6% | -$21.15M-138% | ||
| $641.62M+6.7% | $606.3M-1.0% | $614.5M+3.0% | $608.97M+5.8% | $601.43M+5.4% | ||
| $1.8B+19.0% | $1.91B+20.4% | $1.84B+21.5% | $1.58B+6.7% | $1.51B+9.4% | ||
| $444.61M+4.1% | $442.95M+4.2% | $434.99M+0.9% | $440.33M+3.5% | $427.23M-2.9% | ||
| $593.8M-0.6% | $595.47M-0.3% | $595.95M-0.4% | $597.41M-0.2% | $597.5M-0.2% | ||
| $534.87M-22.4% | $563.5M-23.1% | $587.94M-24.6% | $649.55M-20.8% | $689.14M-19.8% | ||
| $3.54B+5.2% | $3.68B+5.1% | $3.6B+4.0% | $3.42B-2.5% | $3.37B-2.6% | ||
| $6.2M-80.5% | $6.76M-97.0% | $7.2M-96.8% | $31.18M-86.2% | $31.79M-5.6% | ||
| $728.05M-32.3% | $881.63M-22.0% | $862.11M-21.3% | $1.11B-0.6% | $1.08B+28.9% | ||
| $2.57B+19.1% | $2.57B+18.7% | $2.57B+18.3% | $2.15B-1.4% | $2.15B-9.4% | ||
| $2.77B+18.0% | $2.79B+15.5% | $2.78B+15.9% | $2.36B-1.6% | $2.35B-11.0% | ||
| —— | —— | —— | —— | —— | ||
| -$472.75M+20.5% | -$535.01M+11.9% | -$570.08M+1.0% | -$572.45M+0.6% | -$594.87M-2.2% | ||
| -$45.41M+65.5% | -$70.79M+35.2% | -$109.46M-17.2% | -$112.12M-95.1% | -$131.67M-107% | ||
| $3.54B+5.2% | $3.68B+5.1% | $3.6B+4.0% | $3.42B-2.5% | $3.37B-2.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amneal Pharmaceuticals, Inc.'s total assets?
- Amneal Pharmaceuticals, Inc. (AMRX) holds $3.5B in total assets, up 5.2% year over year.
- How much debt does Amneal Pharmaceuticals, Inc. have?
- Amneal Pharmaceuticals, Inc. carries $2.6B in total debt against -$45.4M of shareholders' equity, a debt-to-equity ratio of 127.90.
- How much cash does Amneal Pharmaceuticals, Inc. have?
- Amneal Pharmaceuticals, Inc. holds $197.7M in cash and equivalents.
- Can Amneal Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 2.47 — current assets exceed current liabilities.
- Where does Amneal Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
